2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes

被引:114
作者
Boles, KS
Stepp, SE
Bennett, M
Kumar, V
Mathew, PA
机构
[1] Univ N Texas, Ctr Hlth Sci, Dept Mol biol & Immunol, Ft Worth, TX 76107 USA
[2] Univ N Texas, Ctr Hlth Sci, Canc Res Inst, Ft Worth, TX 76107 USA
[3] Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75230 USA
[4] Univ Chicago, Sch Med, Dept Pathol, Chicago, IL 60637 USA
关键词
D O I
10.1034/j.1600-065X.2001.1810120.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
2B4 is a member of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer (NK) cells and other leukocytes. It is the high affinity ligand for CD48. Engagement of 2B4 on NK-cell surfaces with specific antibodies or CD48 can trigger cell-mediated cytotoxicity, interferon-gamma secretion, phosphoinositol turnover and NK-cell invasiveness. The function of 2B4 in CD8(+) T cells and myeloid cells remains unknown, The cytoplasmic domain of 2B4 contains unique tyrosine motifs (TxYxxV/I) that associate with src homology 2 domain-containing protein or signaling lymphocyte activation molecule (SLAM)-associated protein, whose mutation is the underlying genetic defect in the X-linked lymphoproliferative disease (XLPD). Impaired signaling via 2B4 and SLAM is implicated in the immunopathogenesis of XLPD. CS I is a novel member of the CD2 subset that contains two of the unique tyrosine motifs present in 2B4 and SLAM. Signaling through 2B4, CS I and other members of the CD2 subset may play a major role in the regulation of NK cells and other leukocyte functions.
引用
收藏
页码:234 / 249
页数:16
相关论文
共 145 条
  • [31] EXON INTRON ORGANIZATION AND SEQUENCE COMPARISON OF HUMAN AND MURINE T11 (CD2) GENES
    DIAMOND, DJ
    CLAYTON, LK
    SAYRE, PH
    REINHERZ, EL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) : 1615 - 1619
  • [32] THE HUMAN CD46 MOLECULE IS A RECEPTOR FOR MEASLES-VIRUS (EDMONSTON STRAIN)
    DORIG, RE
    MARCIL, A
    CHOPRA, A
    RICHARDSON, CD
    [J]. CELL, 1993, 75 (02) : 295 - 305
  • [33] Dufourcq-Lagelouse R, 1999, INT J MOL MED, V4, P127
  • [34] A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts
    Dustin, ML
    Olszowy, MW
    Holdorf, AD
    Li, J
    Bromley, S
    Desai, N
    Widder, P
    Rosenberger, F
    van der Merwe, PA
    Allen, PM
    Shaw, AS
    [J]. CELL, 1998, 94 (05) : 667 - 677
  • [35] Ferrante P, 1998, J IMMUNOL, V160, P1514
  • [36] CD48 may serve as an accessory molecule for the activation of a subset of human gamma/delta T cells
    Flament, C
    Benlagha, K
    Rosenthal-Allieri, A
    Chouaib, S
    Mami-Chouaib, F
    [J]. HUMAN IMMUNOLOGY, 1996, 46 (02) : 82 - 92
  • [37] GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60
  • [38] CD48-deficient mice have a pronounced defect in CD4+ T cell activation
    González-Cabrero, J
    Wise, CJ
    Latchman, Y
    Freeman, GJ
    Sharpe, AH
    Reiser, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) : 1019 - 1023
  • [39] Adoptive cellular immunotherapy for EBV lymphoproliferative diseases
    Heslop, HE
    Rooney, CM
    [J]. IMMUNOLOGICAL REVIEWS, 1997, 157 : 217 - 222
  • [40] Human B cell differentiation:: Dependence on interactions with monocytes and T lymphocytes via CD40, Cd80 (B7.1), and the CD2-ligands CD48 and CD58 (LFA-3)
    Hoffmann, JC
    Krüger, H
    Zielen, S
    Bayer, B
    Zeidler, H
    [J]. CELL BIOLOGY INTERNATIONAL, 1998, 22 (01) : 21 - 29